共 338 条
[1]
Kondola S(2016)Malignant pleural mesothelioma: an update on diagnosis and treatment options Ther Adv Respir Dis 10 275-288
[2]
Manners D(2013)Tumours associated with Pathology 45 116-126
[3]
Nowak A(2014) mutations Genes Chromosom Cancer 53 177-182
[4]
Murali R(2015)Expanding the clinical phenotype of hereditary Diagn Cytopathol 43 563-576
[5]
Wiesner T(2013) cancer predisposition syndrome, reporting three new cases Pathology 45 44-48
[6]
Scolyer RA(2010)Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology Diagn Cytopathol 38 874-887
[7]
Pilarski R(2013)A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit Cancer Cytopathol 121 703-707
[8]
Cebulla CM(2013)The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma J Clin Pathol 66 847-853
[9]
Massengill JB(1997)The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey Chest 111 106-109
[10]
Rai K(1993)Challenges and controversies in the diagnosis of mesothelioma: part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia and biomarkers Diagn Cytopathol 9 25-31